Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN
- Citation:
- Blood Adv vol 5 (4) 1092-6
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- AFT
- Endpoint:
- Secondary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 10
- Parents:
- 3402
- Children:
- None
- Pharmas:
- Janssen Oncology
- Grants:
- Alliance Foundation Trials
- Corr. Author:
- Authors:
- Peter M. Voorhees Cesar Rodriguez Brandi Reeves Nitya Nathwani Luciano J. Costa Yana Lutska Padma Bobba Daniela Hoehn Huiling Pei Jon Ukropec Ming Qi Thomas S. Lin Paul G. Richardson
- Networks:
- CA043, LAPS-AL002, LAPS-MA036, LAPS-NC007, LAPS-OH007, NC002
- Study
- AFT-29 (GRIFFIN)
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: